Pulmonary Function Testing (PFT) is a pivotal tool in diagnosing and managing patients with respiratory diseases. However, interpreting the results can be complex and challenging. This article aims to provide a comprehensive guide to interpreting these tests.
Before diving into interpretation, it is crucial to understand the basics of PFT. The tests primarily measure lung volume, capacity, rates of flow, and gas exchange. These parameters provide insights into the functioning of the respiratory system and help identify any abnormalities.
Spirometry is the most common PFT, measuring the volume and speed of air that can be inhaled and exhaled. Key values include Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), and their ratio (FEV1/FVC). Obstructive diseases, such as COPD, present with reduced FEV1/FVC, while restrictive diseases, like pulmonary fibrosis, show reduced FVC with normal or increased FEV1/FVC.
Diffusing capacity of the lungs for carbon monoxide (DLCO) is a measure of gas exchange across the alveolar-capillary membrane. Reduced DLCO can indicate emphysema, pulmonary fibrosis, or pulmonary vascular diseases.
Residual Volume (RV), Total Lung Capacity (TLC), and Functional Residual Capacity (FRC) are measured using body plethysmography. Increased RV and FRC suggest air trapping, common in obstructive diseases, while decreased TLC indicates restrictive diseases.
Interpreting PFTs is an integral part of diagnosing and managing respiratory conditions. Understanding the nuances of the different parameters and their implications can greatly enhance clinical decision-making. Continuous learning and practice are vital to mastering this skill.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation